Abstract 4832: Isolation and molecular characterization of circulating melanoma cells
Xi Luo(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute), Anya M. Kimura(Harvard University), Devarati Mitra(Brigham and Women's Hospital), Keith T. Flaherty(Cancer Research Center), Mai P. Hoang(Harvard University), Donald P. Lawrence(Massachusetts General Hospital), Brian W. Brannigan(Harvard University), Ben S. Wittner(Broad Institute), Shyamala Maheswaran(Massachusetts General Hospital), Shannon L. Stott(Shriners Hospitals for Children - Erie), Shiwei Pan(Harvard University), Lecia V. Sequist(Harvard University), Mehmet Toner(Center for Cancer Research), David E. Fisher(Massachusetts General Hospital), Ryan J. Sullivan(Dana-Farber Cancer Institute), Sridhar Ramaswamy(Harvard University), David T. Ting(Massachusetts General Hospital)
Cited by 1
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k